Nirogacestat Linked With Improved Functional Status in Patients With Desmoid Tumors
Nirogacestat (Ogsiveo) was associated with significant and clinically meaningful improvements in functional…
SpringWorks Therapeutics Announces European Medicines
STAMFORD, Conn., Feb. 29, 2024 (GLOBE NEWSWIRE) -- SpringWorks Therapeutics, Inc. (Nasdaq:…
EMA Validates Marketing Application for Nirogacestat in Desmoid Tumors
"These results support that nirogacestat will be a practice-changing therapy if approved…
SpringWorks Therapeutics Announces European Medicines Agency Validation for Marketing Authorization Application of Nirogacestat for the Treatment of Adults with Desmoid Tumors
SpringWorks Therapeutics, Inc.Application based on Phase 3 DeFi trial in which nirogacestat…
Psychosocial Impact and Pain Management for Desmoid Tumors
This is a video synopsis/summary of a Peer Exchange involving Ryan Haumschild,…
Turning to Patients to Help Drive Rare Disease Drug Development
Pictured: A physician stands with a family against a drug development background/Nicole…
Impact and Quality of Life
This is a video synopsis/summary of a Peer Exchange involving Ryan Haumschild,…
Ayala Pharmaceuticals Announces Completion of Enrollment in Phase 3 RINGSIDE Study Evaluating AL102 in Desmoid Tumors
Ayala PharmaceuticalsREHOVOT, Israel and MONMOUTH JUNCTION, N.J., Feb. 20, 2024 (GLOBE NEWSWIRE)…
AJMC® in the Press, February 16, 2024
Articles in Fierce Healthcare and HealthExec referenced a study published in the…